Chesnara (LON:CSN)‘s stock had its “house stock” rating reaffirmed by analysts at Shore Capital in a research report issued to clients and investors on Monday.

Shares of Chesnara (LON CSN) remained flat at $GBX 385.25 ($5.19) during midday trading on Monday. 37,594 shares of the company’s stock traded hands, compared to its average volume of 166,399. Chesnara has a 52-week low of GBX 326 ($4.39) and a 52-week high of GBX 419.75 ($5.65).

In related news, insider John Deane acquired 10,000 shares of the company’s stock in a transaction on Friday, November 24th. The stock was purchased at an average cost of GBX 350 ($4.71) per share, for a total transaction of £35,000 ($47,106.33). Also, insider David Rimmington sold 15,011 shares of the stock in a transaction on Monday, November 6th. The stock was sold at an average price of GBX 388 ($5.22), for a total value of £58,242.68 ($78,388.53).

COPYRIGHT VIOLATION NOTICE: “Shore Capital Reaffirms “House Stock” Rating for Chesnara (CSN)” was published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at

About Chesnara

Chesnara plc is a holding company, which is engaged in the management of life and pension books of business in the United Kingdom and Western Europe. The Company focuses on specialist insurance business in the life insurance and pensions sector in the Netherlands. Its segments include CA, S&P, Movestic, The Waard Group and Other Group Activities.

Receive News & Ratings for Chesnara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara and related companies with's FREE daily email newsletter.